Old Web
English
Sign In
Acemap
>
authorDetail
>
Yaling Dou
Yaling Dou
Houston Methodist Hospital
Biology
Cell biology
Downregulation and upregulation
Lymphoma
Tumor progression
5
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Structural and Mechanistic Insights into TRIM E3 Ubiquitin Ligase Activities
2021
Xiaohua Lou
Yuan Zhuang
Binbin Ma
Yaling Dou
Guangchuan Wang
Xiang Xiao
Laurie J. Minze
Junji Xing
Zhiqiang Zhang
Xian Chang Li
Show All
Source
Cite
Save
Citations (0)
Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
2019
Journal of Hematology & Oncology
Yuanhui Liu
Nancy G. Azizian
Yaling Dou
Lan V. Pham
Yulin Li
Show All
Source
Cite
Save
Citations (9)
Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions
2019
Journal of Immunology
Yaling Dou
Junji Xing
Gangcheng Kong
Guangchuan Wang
Xiaohua Lou
Xiang Xiao
Eric Vivier
Xian Chang Li
Zhiqiang Zhang
Show All
Source
Cite
Save
Citations (10)
Simultaneous Targeting of XPO1 and BCL2 as an Effective Treatment Strategy for Double-Hit Lymphoma
2019
bioRxiv
Yuanhui Liu
Nancy G. Azizian
Yaling Dou
Lan V. Pham
Yulin Li
Show All
Source
Cite
Save
Citations (1)
Identification of Trim29 as a Key checkpoint inhibitor of natural killer cell functions
2018
Immunology
Yaling Dou
Junji Xing
Xian Chang Li
Zhiqiang Zhang
Show All
Source
Cite
Save
Citations (0)
1